IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

23 hedge funds and large institutions have $21.1M invested in Insight Molecular Diagnostics Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
8
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BC
1
Broadwood Capital
New York
$14.5M
2
AIC
2
AWM Investment Company
New York
$3.24M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$273K
4
FIA
4
FNY Investment Advisers
New York
$69K
5
Northern Trust
5
Northern Trust
Illinois
$51.2K

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$232K
2
PVI
2
Pura Vida Investments
New York
$1.46M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$721K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$30.7K
5
DC
5
Defender Capital
North Carolina
$163K
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
– – -61 Closed
Comerica Bank
27
Comerica Bank
Texas
– – -23 Closed
Fidelity Investments
28
Fidelity Investments
Massachusetts
– – -13 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
– – – –
1
2